Quantcast

Md. biopharm gets patent for cancer medicine candidate

Rexahn Pharmaceuticals Inc., a Rockville biopharmaceutical company, has received a U.S. patent for new formulations of its cancer drug candidate, Supinoxin.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.